Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP) header
Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP) profile picture

Assistant Professor of Rheumatology @uanl | LUMEN Research Collaborator @mayoclinic | Tweets are my own / 🐘☕🩺📖 / Left-handed.

25.68597,-100.346851
Joined June 2009
Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)Photo by Gabriel Figueroa-Parra, MD, MSc (@DrGabrielFP)
Scientific Oath 🙋🏻‍♂️ I promise to work for a better world, where science and technology are used in socially responsible ways. I will not use my education for any purpose intended to harm human beings or the environment... 1/2
1
11
Gabriel Figueroa-Parra, MD, MSc retweeted
🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋 Just Released: Nov 3 #ACR25 🔥 🔸Review organ-specific treatment recommendations 🔸Steroid & HCQ Use Guidance ➠ Read the Full Guideline: acr.tw/47mkegj #RheumX #RheumTwitter #Rheum @RheumNow
2
117
3
317
33,094
Gabriel Figueroa-Parra, MD, MSc retweeted
Now published: The 2025 ACR Guideline for the Treatment of Systemic Lupus Erythematosus 📄 Read the paper: acr.tw/47mkegj ℹ️ See additional content and resources on this guideline at acr.tw/4mbHK4W
1
128
329
21,612
Gabriel Figueroa-Parra, MD, MSc retweeted
NEW! The ACR just released an updated clinical practice guideline for #SLE! Key recommendations include universal hydroxychloroquine use, lower steroid exposure, & earlier immunosuppressive therapy. Patient-centered care is central. READ MORE → acr.tw/4oAFS6q
6
10
1,186
Great summary! – at Monterrey, Nuevo León
NEW ACR clinical practice guideline provides recommendations regarding treatment of systemic lupus erythematosus (SLE) in both adults and children. FULL GUIDELINE → acr.tw/4mbHK4W #SLE #lupus
2
141
Gabriel Figueroa-Parra, MD, MSc retweeted
Honored to present our work at #ACR25: “Differential Risk of Inpatient Admissions Among SLE Subgroups: A Population-Based Analysis.” Grateful to my mentor @AliDuarteMD and the LUMEN team for their outstanding collaboration and guidance. #Rheumatology #Lupus #LupusResearch
1
4
27
2,275
Happy with my friend Mario Bautista, receiving the "Griffing-Nelson Award" during the Hench Society event for his outstanding abstract! All invited to the presentation #today at S102 (SLE abstracts) #ACR2025 – at Chicago, IL
2
7
607
Gabriel Figueroa-Parra, MD, MSc retweeted
Congratulations to Eric L. Matteson, MD, MPH, recipient of the 2025 Presidential Gold Medal Award! @MayoClinic #ACR25
6
3
20
2,651
🚨🚨🚨
NEW #SLE clinical practice guideline to be unveiled at #ACR25! ✨ Don’t miss this important session—2025 American College of Rheumatology Guideline for the Treatment of Systemic Lupus Erythematosus, Saturday, Oct. 26, 9:00-10:30 AM CT. DETAILS → acr.tw/3WkE8SI COMING SOON: Full guideline manuscript. Stay tuned 👀 → acr.tw/43u8XGi
77
Gabriel Figueroa-Parra, MD, MSc retweeted
YAP1-CCN2 signaling enables proproliferative communication between microvascular ECs and vascular SMCs in patients with antiphospholipid syndrome (APS) vasculopathy. Inhibiting the pathway could lead to a targeted treatment approach @RayZuoMD @DrGabrielFP ahajournals.org/doi/full/10.…
2
14
2,226
Gabriel Figueroa-Parra, MD, MSc retweeted
#ACR25 abstracts now online! 🎉 Browse over 3,100 abstracts representing the highest-impact research in the field of #rheum. NOTE: Information that goes beyond that contained in the abstract is under media embargo until Oct. 25 at 10:00 AM CT. View 👀 → acr.tw/30RaIzl
1
10
3
16
2,522
Gabriel Figueroa-Parra, MD, MSc retweeted
NEW EPISODE! Alain Sanchez-Rodriguez, MD, joins the podcast to discuss delays in #lupus diagnosis & care based on findings from the Lupus Midwest Network (LUMEN)🎙️LISTEN NOW → acr.tw/3UWKCXi @ACR_Journals
3
8
3
20
1,955
📢📢 Oficialmente, las guías 2024 del ACR para nefritis lúpica disponibles en extenso!!
Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis See ACR guideline page for resources - rheumatology.org/lupus-guide… DOI link - doi.org/10.1002/acr.25528 Download the article - acr.tw/44sRwJM
177
I wasn't expecting this! 😮 Shout-out to @MariaCuellarMD, @AliDuarteMD, and all the team!
This Post is from an account that no longer exists. Learn more
1
2
450
Gabriel Figueroa-Parra, MD, MSc retweeted
1
3
12
593
Gabriel Figueroa-Parra, MD, MSc retweeted
🚨New Research Alert 🚨 Excited to share our latest study in @TheLancetRheum We analyzed the accuracy, quality, and safety of Large Language Models —ChatGPT-4, Claude 3: Opus and Gemini Advanced— in rheumatology board-like questions. Read more: thelancet.com/journals/lanrh…
1
4
1
13
1,981
This study is derived from my master’s degree thesis. I would like to thank my mentors @AliDuarteMD, @CrowsonCindy, and my TAC: Matthew J. Koster, MD, @LadanZand, and @mugartegil. Also, thanks to all coauthors and funding sources that made this project possible.
1
3
207